Interventional Cardiologist in VIC
Biography
Professor Stephen Duffy is a practising Interventional and General Cardiologist at the Alfred Health where he was the Head of Cardiology General Services for 9 nine years. He is currently an Adjunct Professor, Department of Epidemiology and Preventative Medicine at the Monash University. His clinical interests include interventional cardiology, management of acute coronary syndromes and structural heart disease. Together with Tony Walton, Pr Read More...
Procedures & Conditions
Procedures Performed
- General Cardiology
- Transcatheter Aortic Valve Implantation (TAVI)
- Transcatheter Mitral Valve Implantation
Conditions Treated
- Aortic Stenosis
- Structural Heart Disease
- Coronary Artery Disease
- Acute Coronary Syndromes
- Ischaemic Heart Disease
- Myocardial Infarction
Experience
-
Academic Fellow
Baker Heart & Diabetes Institute 2011 - Present -
Consultant Cardiologist
The Alfred Hospital, Melbourne, Australia 2010 - Present -
Head of Cardiology General Services
The Alfred Hospital, Melbourne, Australia 2005 - 2018 -
Head of Coronary Pathophysiology Laboratory
Baker IDI Heart & Diabetes Institute 2003 - 2015 -
Consultant Cardiologist
The Alfred Hospital, Melbourne, Australia 2001 - Present -
Interventional Cardiology Fellow and Research Associate
Evans Department of Medicine, Boston University School of Medicine & Boston University Medical Centre 1999 - 2001 -
Cardiologist
Cardiology Unit, Monash Medical Centre 1996 -1998 -
NHMRC Cardiovascular Research Scholar and Ph.D. Student
Centre for Heart and Chest Research, Monash Medical Centre & Monash University 1995 -1998
Memberships & Awards
Professional Memberships and Affiliations
-
Royal Australian College of Physicians Fellow
-
Royal College of Physicians UK Member
-
The Cardiac Society of Australia and New Zealand Fellow
-
American Heart Association, Arteriosclerosis, Thrombosis & Vascular Biology Scientific Council Member
Awards
-
1996
Cardiac Society of Australia & New Zealand Annual Scientific Meeting Travelling Scholarship
-
1996
Cardiac Society of Australia & New Zealand Annual Scientific Meeting Poster Prize
-
1996
Cardiac Society of Australia & New Zealand Travelling Fellowship
-
1997
Cardiac Society of Australia & New Zealand “Bayer Travelling Fellowship”
-
1997
Southern Health Care Network “AMRAD Postgraduate Education Research Travel Grant”
-
1997
Cardiac Society of Australia & New Zealand Travelling Fellowship
-
1998
Cardiac Society of Australia & New Zealand Annual Scientific Meeting Poster Prize
-
2000
Cardiac Society of Australia & New Zealand Annual Scientific Meeting Travelling Scholarship
Research & Publications
Publications
1. du Peloux Menage H., Duffy, S., Yates, D.W., Hughes, J.A. Reversible sensorimotor impairment following prolonged ventilation with isoflurane and vecuronium for acute severe asthma. Thorax, 1992; 47: 1078-9.
2. New, G., Timmins, K.L., Duffy, S.J., Tran, B.T., O’Brien, R.C., Harper, R.W., Meredith, I.T. Long-term estrogen therapy improves vascular function in male to female transsexuals. Journal of the American College of Cardiology, 1997; 29: 1437-44.
3. Duffy, S.J., Tran, B.T., New, G., Tudball, R.N., Esler, M.D., Harper, R.W., Meredith, I.T. Continuous release of vasodilator prostanoids contributes to the regulation of resting forearm blood flow in humans. American Journal of Physiology, 1998; 274: H1174-83.
4. Duffy, S.J., New, G., Tran, B.T., Harper, R.W., Meredith, I.T. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. American Journal of Physiology, 1999; 276: H663-70.
5. New, G., Duffy, S.J., Berry, K.L., Harper, R.W., Meredith, I.T. Acute administration of 17-oestradiol does not improve endothelium-dependent vasodilation in young men. Clinical Science, 1999; 97: 225-32.
6. Duffy, S.J., New, G., Harper, R.W., Meredith, I.T. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation.Cardiovascular Research, 1999; 43: 721-30.
7. Duffy, S.J., Castle, S.F., Harper, R.W., Meredith, I.T. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation and flow-mediated dilation in human coronary circulation. Circulation, 1999; 100: 1951-7.
8. New, G., Duffy, S.J., Harper, R.W., Meredith, I.T. Estrogen improves acetylcholine-induced, but not metabolic, vasodilation in biological males. American Journal of Physiology, 1999; 277: H2341-7.
9. Duffy, S.J., Gokce, N., Holbrook, M., Huang, A., Frei, B., Keaney, J.F., Jr., Vita, J.A. Treatment of hypertension with ascorbic acid. Lancet, 1999; 354: 2048-9.
10. New, G., Duffy, S.J., Harper, R.W., Meredith, I.T. Long-term oestrogen therapy is associated with improved endothelium-dependent vasodilation in the forearm resistance circulation of biological males. Clinical and Experimental Pharmacology and Physiology, 2000; 27: 25-33.
11. Sherman, D.L., Keaney, J.F., Jr., Biegelsen, E.S., Duffy, S.J., Coffman, J.D., Vita, J.A. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension, 2000; 35: 936-41.
12. Duffy, S.J., Gokce, N., Holbrook, M., Hunter, L.M., Biegelsen, E.S., Huang, A., Keaney, J.F., Jr., Vita, J.A. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. American Journal of Physiology, 2001; 280: H528-34.
13. Duffy, S.J., Gelman, J.S., Peverill, R.E., Greentree, M.A., Harper, R.W., Meredith, I.T. Agreement between coronary flow velocity reserve and stress echocardiography in intermediate severity coronary stenoses. Catheterization and Cardiovascular Interventions, 2001; 53: 29-38.
14. Duffy, S.J., O’Brien, R.C., New, G., Bond, A.M., Harper, R.W., Meredith, I.T. Effect of antioxidant treatment and cholesterol lowering on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized, placebo-controlled study. Clinical and Experimental Pharmacology and Physiology, 2001; 28: 409-18.
15. Duffy, S.J., Vita, J.A., Holbrook, M., Swerdloff, P.L., Keaney, J.F., Jr. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 2001; 21: 1084-89.
16. Duffy, S.J., Biegelsen, E.S., Holbrook, M., Russell, J.D., Gokce, N., Keaney, J.F., Jr., Vita, J.A. Iron chelation improves endothelial function in patients with coronary artery disease.Circulation, 2001; 103: 2799-2804.
17. Duffy, S.J., Alison, J.F. Permanent pacemaker implantation via a persistent left superior vena cava.Clinical Cardiology, 2001; 24: 526.
18. Duffy, S.J., Keaney, J.F., Jr., Holbrook, M., Gokce, N., Swerdloff, P.L., Frei, B., Vita, J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 2001; 104: 151-6.
19. Gokce, N., Duffy, S.J., Hunter, L.M., Keaney, J.F., Jr., Vita, J.A. Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults.
American Journal of Cardiology, 2001; 88: 153-9.
20. Gokce, N., Holbrook, M., Duffy, S.J., Demissie, S., Cupples, L.A., Biegelsen, E., Keaney, J.F., Jr., Loscalzo, J., Vita, J.A. Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension, 2001; 38: 1349-54.
21. Kahn, D.F., Duffy, S.J., Tomasian, D., Holbrook, M., Rescorl, L., Russell, J., Gokce, N., Loscalzo, J., Vita, J.A. Effects of black race on forearm resistance vessel function.Hypertension, 2002; 40: 195-201.
22. Vita J.A., Gokce N., Duffy S.J., Kahn D.F., Tomasian D., Palmisano J., Thomas S., Holbrook M., Keaney J.F., Jr. Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease. American Journal of Cardiology, 2003; 91: 857-60.
23. Widlansky, M.E., Price, D.T., Gokce, N., Eberhardt, R.T., Duffy, S.J., Holbrook, M., Maxwell, C., Palmisano, J., Keaney, J.F., Jr., Morrow, J.D., Vita, J.A. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension, 2003; 42: 310-5.
24. Eberhardt, R.T., McMahon, L., Duffy, S.J., Steinberg, M.H., Perrine, S.P., Loscalzo, J., Coffman, J.D., Vita, J.A. Sickle cell disease is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. American Journal of Hematology, 2003; 74: 104-11.
25. Widlansky, M.E., Biegelsen, E.S., Hamburg, N.M., Duffy, S.J., Keaney, J.F., Jr., Vita, J.A. Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid.Free Radical Biology and Medicine, 2004; 36: 123-30.
26. Widlansky, M.E., Duffy, S.J., Hamburg, N.M., Gokce N., Warden, B.A., Wiseman, S., Keaney, J.F., Jr., Frei, B., Vita, J.A. Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radical Biology and Medicine, 2005; 38: 499-506.
27. Duffy, S.J., Biegelsen, E.S., Eberhardt, R.T., Kahn, D.F., Kingwell, B.A., Vita, J.A. Low-renin hypertension with relative aldosterone excess is associated with impaired nitric oxide-mediated vasodilation. Hypertension, 2005; 46: 707-13.
28. Boak, L.M., Dart, A.M., Duffy, S.J., Chin-Dusting, J.P.F. Neither responses to exogenous nor endogenous endothelin-1 are altered in patients with hypercholesterolemia. Journal of Lipid Research, 2005; 46: 2667-72.
29. Henstridge, D.C., Kingwell, B.A., Formosa, M.F., Drew, B.G., McConell, G.K., Duffy, S.J. Effects of the nitric oxide donor, sodium nitroprusside on resting leg glucose uptake in patients with type 2 diabetes. Diabetologia, 2005; 48: 2602-8.
30. Ajani, A.E., Szto, G., Duffy, S.J., Eccleston, D., Clark, D.J., Lefkovits, J., Chew, D.P., Warren, R., Black, A., New, G., Walton, A., Lew, R., Shaw, J., Horrigan, M., Sebastian, M., Yan, B.P., Brennan, A., Meehan, A., Reid, C., Krum, H. The foundation and launch of the Melbourne Interventional Group: A collaborative interventional cardiology project. Heart, Lung and Circulation, 2006; 15: 44-7.
More publications available upon request.
View MorePresentations
- Coronary Doppler Velocimetry: Assessment of Intermediate Severity Stenoses Monash Interventional Cardiology 2nd International Symposium on Coronary Stenting, April 1996
- Optimising Interventions: Doppler FloWire Monash Interventional Cardiology 3rd International Symposium on Coronary Stenting, April 1997
- Endothelial Control of Coronary Blood Flow 2nd Cardiovascular Registrars Research Forum Ayers Rock, Northern Territory, May 1998
- Iron – A Novel Risk Factor for Atherosclerosis? – The Effect of Iron Chelation on Endothelial Function Vascular Biology Workshop in honour of Visiting Professor Richard A. Walsh, MD, Boston University Medical Center, February 2000
- Cardiovascular Effects of Black Tea. Victorian Heart Centre Cardiovascular Meeting, August 2001
- Cardiovascular Protection in Hypertension – The Endothelium George Institute for Global Health, Sydney, October 2001
- Biomarkers in Acute Coronary Syndromes Baker Heart Research Institute 80th Birthday Symposium, October 2006
- Stent Thrombosis in Drug-Eluting Stents National Registrars and Fellows Interventional Meeting, 2007
- Anti-Platelet Therapy Following PCI Cardiac Society of Australia and New Zealand (CSANZ) Annual Scientific Meeting 2008; Symposium on Anti-Platelet Therapy Stent Thrombosis in Drug-Eluting Stents National Registrars and Fellows Interventional Meeting, 2009
- PCI Complications: Stent Thrombosis National Registrars and Fellows Interventional Meeting, 2010
- Stent Thrombosis – Yesterday’s News? Essential Percutaneous Intervention Course (EPIC), 2011
- Interventional Nightmares Australia & New Zealand Endovascular Therapies (ANZET) Meeting, 2013
- Issues in ST-Elevation Myocardial Infarction SAHMRI Masterclass Series, 2014
- Peripheral Vascular Management in TAVI Australia & New Zealand Endovascular Therapies (ANZET) Meeting, 2016
- Eulogy for Henry Krum Cardiac Society of Australia and New Zealand (CSANZ) Annual Scientific Meeting 2016; Heart Failure Council Symposium
- TAVI Valve-in-Valve Implantation Essential Percutaneous Intervention Course (EPIC), 2017
- Transcatheter Mitral Valve Implantation, Essential Percutaneous Intervention Course (EPIC), 2018
Related Articles
Understanding Patient Preferences in Heart Valve Disease Treatment
Heart valve disease (HVD) is a significant health issue in…
Mitral Valve Regurgitation: Symptoms, Causes & Treatment
Mitral Valve Regurgitation (MVR) is the most common valvular abnormality…
Chest Pain: Everything you need to know
What is Chest Pain? Chest pain describes a feeling of…